Cargando…
Variability in Exposure of Epitope G40-R43 of Domain I in Commercial Anti-Beta2-Glycoprotein I IgG ELISAs
BACKGROUND: A major problem for diagnosing the antiphospholipid syndrome (APS) is the high variability between commercial anti-β(2)glycoprotein I (β(2)GPI) assays. Predominantly antibodies reactive against cryptic epitope Glycine40-Arginine43 (G40-R43) in domain I are associated with an increased ri...
Autores principales: | Pelkmans, Leonie, Kelchtermans, Hilde, de Groot, Philip G., Zuily, Stephane, Regnault, Veronique, Wahl, Denis, Pengo, Vittorio, de Laat, Bas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3741166/ https://www.ncbi.nlm.nih.gov/pubmed/23951154 http://dx.doi.org/10.1371/journal.pone.0071402 |
Ejemplares similares
-
Brief Report on the 11th Meeting of the European Forum on Antiphospholipid Antibodies
por: Chayouâ, Walid, et al.
Publicado: (2019) -
Influence of anticardiolipin and anti‐β2 glycoprotein I antibody cutoff values on antiphospholipid syndrome classification
por: Vanoverschelde, Laura, et al.
Publicado: (2019) -
Autoantibodies Directed Against Domain I of Beta2-Glycoprotein I
por: de Laat, Bas, et al.
Publicado: (2010) -
Epitope-Specific Suppression of IgG Responses by Passively Administered Specific IgG: Evidence of Epitope Masking
por: Bergström, Joakim J. E., et al.
Publicado: (2017) -
Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG
por: Sapkal, Gajanan, et al.
Publicado: (2020)